Global Contraceptives Drugs and Devices Market Growth 2023-2029

February 2023 | 107 pages | ID: GF4AFFDB61E3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

LPI (LP Information)' newest research report, the “Contraceptives Drugs and Devices Industry Forecast” looks at past sales and reviews total world Contraceptives Drugs and Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Contraceptives Drugs and Devices sales for 2023 through 2029. With Contraceptives Drugs and Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptives Drugs and Devices industry.

This Insight Report provides a comprehensive analysis of the global Contraceptives Drugs and Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptives Drugs and Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Contraceptives Drugs and Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptives Drugs and Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptives Drugs and Devices.

The global Contraceptives Drugs and Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Contraceptives Drugs and Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Contraceptives Drugs and Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Contraceptives Drugs and Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Contraceptives Drugs and Devices players cover Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc and Allergan plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives Drugs and Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
  • Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Segmentation by application
  • Female
  • Male
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Teva Pharmaceutical Industries Ltd
  • Church & Dwight Co. Inc
  • Reckitt Benckiser Plc
  • Pfizer, Inc
  • Bayer AG
  • Mayer Laboratories, Inc
  • The Female Health Company
  • Cooper Surgical, Inc
  • Allergan plc
  • Cipla Limited
  • Merck & Co. Inc
Key Questions Addressed in this Report

What is the 10-year outlook for the global Contraceptives Drugs and Devices market?

What factors are driving Contraceptives Drugs and Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Contraceptives Drugs and Devices market opportunities vary by end market size?

How does Contraceptives Drugs and Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Contraceptives Drugs and Devices Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Contraceptives Drugs and Devices by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Contraceptives Drugs and Devices by Country/Region, 2018, 2022 & 2029
2.2 Contraceptives Drugs and Devices Segment by Type
  2.2.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
  2.2.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
2.3 Contraceptives Drugs and Devices Sales by Type
  2.3.1 Global Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
  2.3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Contraceptives Drugs and Devices Sale Price by Type (2018-2023)
2.4 Contraceptives Drugs and Devices Segment by Application
  2.4.1 Female
  2.4.2 Male
2.5 Contraceptives Drugs and Devices Sales by Application
  2.5.1 Global Contraceptives Drugs and Devices Sale Market Share by Application (2018-2023)
  2.5.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Contraceptives Drugs and Devices Sale Price by Application (2018-2023)

3 GLOBAL CONTRACEPTIVES DRUGS AND DEVICES BY COMPANY

3.1 Global Contraceptives Drugs and Devices Breakdown Data by Company
  3.1.1 Global Contraceptives Drugs and Devices Annual Sales by Company (2018-2023)
  3.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Company (2018-2023)
3.2 Global Contraceptives Drugs and Devices Annual Revenue by Company (2018-2023)
  3.2.1 Global Contraceptives Drugs and Devices Revenue by Company (2018-2023)
  3.2.2 Global Contraceptives Drugs and Devices Revenue Market Share by Company (2018-2023)
3.3 Global Contraceptives Drugs and Devices Sale Price by Company
3.4 Key Manufacturers Contraceptives Drugs and Devices Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Contraceptives Drugs and Devices Product Location Distribution
  3.4.2 Players Contraceptives Drugs and Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVES DRUGS AND DEVICES BY GEOGRAPHIC REGION

4.1 World Historic Contraceptives Drugs and Devices Market Size by Geographic Region (2018-2023)
  4.1.1 Global Contraceptives Drugs and Devices Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Contraceptives Drugs and Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Contraceptives Drugs and Devices Market Size by Country/Region (2018-2023)
  4.2.1 Global Contraceptives Drugs and Devices Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Contraceptives Drugs and Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Contraceptives Drugs and Devices Sales Growth
4.4 APAC Contraceptives Drugs and Devices Sales Growth
4.5 Europe Contraceptives Drugs and Devices Sales Growth
4.6 Middle East & Africa Contraceptives Drugs and Devices Sales Growth

5 AMERICAS

5.1 Americas Contraceptives Drugs and Devices Sales by Country
  5.1.1 Americas Contraceptives Drugs and Devices Sales by Country (2018-2023)
  5.1.2 Americas Contraceptives Drugs and Devices Revenue by Country (2018-2023)
5.2 Americas Contraceptives Drugs and Devices Sales by Type
5.3 Americas Contraceptives Drugs and Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Contraceptives Drugs and Devices Sales by Region
  6.1.1 APAC Contraceptives Drugs and Devices Sales by Region (2018-2023)
  6.1.2 APAC Contraceptives Drugs and Devices Revenue by Region (2018-2023)
6.2 APAC Contraceptives Drugs and Devices Sales by Type
6.3 APAC Contraceptives Drugs and Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Contraceptives Drugs and Devices by Country
  7.1.1 Europe Contraceptives Drugs and Devices Sales by Country (2018-2023)
  7.1.2 Europe Contraceptives Drugs and Devices Revenue by Country (2018-2023)
7.2 Europe Contraceptives Drugs and Devices Sales by Type
7.3 Europe Contraceptives Drugs and Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Contraceptives Drugs and Devices by Country
  8.1.1 Middle East & Africa Contraceptives Drugs and Devices Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Contraceptives Drugs and Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Contraceptives Drugs and Devices Sales by Type
8.3 Middle East & Africa Contraceptives Drugs and Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptives Drugs and Devices
10.3 Manufacturing Process Analysis of Contraceptives Drugs and Devices
10.4 Industry Chain Structure of Contraceptives Drugs and Devices

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Contraceptives Drugs and Devices Distributors
11.3 Contraceptives Drugs and Devices Customer

12 WORLD FORECAST REVIEW FOR CONTRACEPTIVES DRUGS AND DEVICES BY GEOGRAPHIC REGION

12.1 Global Contraceptives Drugs and Devices Market Size Forecast by Region
  12.1.1 Global Contraceptives Drugs and Devices Forecast by Region (2024-2029)
  12.1.2 Global Contraceptives Drugs and Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Contraceptives Drugs and Devices Forecast by Type
12.7 Global Contraceptives Drugs and Devices Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Teva Pharmaceutical Industries Ltd
  13.1.1 Teva Pharmaceutical Industries Ltd Company Information
  13.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview
  13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.2 Church & Dwight Co. Inc
  13.2.1 Church & Dwight Co. Inc Company Information
  13.2.2 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Church & Dwight Co. Inc Main Business Overview
  13.2.5 Church & Dwight Co. Inc Latest Developments
13.3 Reckitt Benckiser Plc
  13.3.1 Reckitt Benckiser Plc Company Information
  13.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Reckitt Benckiser Plc Main Business Overview
  13.3.5 Reckitt Benckiser Plc Latest Developments
13.4 Pfizer, Inc
  13.4.1 Pfizer, Inc Company Information
  13.4.2 Pfizer, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.4.3 Pfizer, Inc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Pfizer, Inc Main Business Overview
  13.4.5 Pfizer, Inc Latest Developments
13.5 Bayer AG
  13.5.1 Bayer AG Company Information
  13.5.2 Bayer AG Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.5.3 Bayer AG Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Bayer AG Main Business Overview
  13.5.5 Bayer AG Latest Developments
13.6 Mayer Laboratories, Inc
  13.6.1 Mayer Laboratories, Inc Company Information
  13.6.2 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Mayer Laboratories, Inc Main Business Overview
  13.6.5 Mayer Laboratories, Inc Latest Developments
13.7 The Female Health Company
  13.7.1 The Female Health Company Company Information
  13.7.2 The Female Health Company Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.7.3 The Female Health Company Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 The Female Health Company Main Business Overview
  13.7.5 The Female Health Company Latest Developments
13.8 Cooper Surgical, Inc
  13.8.1 Cooper Surgical, Inc Company Information
  13.8.2 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Cooper Surgical, Inc Main Business Overview
  13.8.5 Cooper Surgical, Inc Latest Developments
13.9 Allergan plc
  13.9.1 Allergan plc Company Information
  13.9.2 Allergan plc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.9.3 Allergan plc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Allergan plc Main Business Overview
  13.9.5 Allergan plc Latest Developments
13.10 Cipla Limited
  13.10.1 Cipla Limited Company Information
  13.10.2 Cipla Limited Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.10.3 Cipla Limited Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Cipla Limited Main Business Overview
  13.10.5 Cipla Limited Latest Developments
13.11 Merck & Co. Inc
  13.11.1 Merck & Co. Inc Company Information
  13.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
  13.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Merck & Co. Inc Main Business Overview
  13.11.5 Merck & Co. Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Contraceptives Drugs and Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Contraceptives Drugs and Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Table 4. Major Players of Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Table 5. Global Contraceptives Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 6. Global Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
Table 7. Global Contraceptives Drugs and Devices Revenue by Type (2018-2023) & ($ million)
Table 8. Global Contraceptives Drugs and Devices Revenue Market Share by Type (2018-2023)
Table 9. Global Contraceptives Drugs and Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Contraceptives Drugs and Devices Sales by Application (2018-2023) & (K Units)
Table 11. Global Contraceptives Drugs and Devices Sales Market Share by Application (2018-2023)
Table 12. Global Contraceptives Drugs and Devices Revenue by Application (2018-2023)
Table 13. Global Contraceptives Drugs and Devices Revenue Market Share by Application (2018-2023)
Table 14. Global Contraceptives Drugs and Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Contraceptives Drugs and Devices Sales by Company (2018-2023) & (K Units)
Table 16. Global Contraceptives Drugs and Devices Sales Market Share by Company (2018-2023)
Table 17. Global Contraceptives Drugs and Devices Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Contraceptives Drugs and Devices Revenue Market Share by Company (2018-2023)
Table 19. Global Contraceptives Drugs and Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Contraceptives Drugs and Devices Producing Area Distribution and Sales Area
Table 21. Players Contraceptives Drugs and Devices Products Offered
Table 22. Contraceptives Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Contraceptives Drugs and Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Contraceptives Drugs and Devices Sales Market Share Geographic Region (2018-2023)
Table 27. Global Contraceptives Drugs and Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Contraceptives Drugs and Devices Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Contraceptives Drugs and Devices Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Contraceptives Drugs and Devices Sales Market Share by Country/Region (2018-2023)
Table 31. Global Contraceptives Drugs and Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Contraceptives Drugs and Devices Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Contraceptives Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 34. Americas Contraceptives Drugs and Devices Sales Market Share by Country (2018-2023)
Table 35. Americas Contraceptives Drugs and Devices Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Contraceptives Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 37. Americas Contraceptives Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 38. Americas Contraceptives Drugs and Devices Sales by Application (2018-2023) & (K Units)
Table 39. APAC Contraceptives Drugs and Devices Sales by Region (2018-2023) & (K Units)
Table 40. APAC Contraceptives Drugs and Devices Sales Market Share by Region (2018-2023)
Table 41. APAC Contraceptives Drugs and Devices Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Contraceptives Drugs and Devices Revenue Market Share by Region (2018-2023)
Table 43. APAC Contraceptives Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 44. APAC Contraceptives Drugs and Devices Sales by Application (2018-2023) & (K Units)
Table 45. Europe Contraceptives Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 46. Europe Contraceptives Drugs and Devices Sales Market Share by Country (2018-2023)
Table 47. Europe Contraceptives Drugs and Devices Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Contraceptives Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 49. Europe Contraceptives Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 50. Europe Contraceptives Drugs and Devices Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Contraceptives Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Contraceptives Drugs and Devices Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Contraceptives Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Contraceptives Drugs and Devices Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Contraceptives Drugs and Devices
Table 58. Key Market Challenges & Risks of Contraceptives Drugs and Devices
Table 59. Key Industry Trends of Contraceptives Drugs and Devices
Table 60. Contraceptives Drugs and Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Contraceptives Drugs and Devices Distributors List
Table 63. Contraceptives Drugs and Devices Customer List
Table 64. Global Contraceptives Drugs and Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Contraceptives Drugs and Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Contraceptives Drugs and Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Contraceptives Drugs and Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Contraceptives Drugs and Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Contraceptives Drugs and Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Contraceptives Drugs and Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Contraceptives Drugs and Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Contraceptives Drugs and Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Contraceptives Drugs and Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Contraceptives Drugs and Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Contraceptives Drugs and Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Contraceptives Drugs and Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Contraceptives Drugs and Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Pharmaceutical Industries Ltd Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 80. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Teva Pharmaceutical Industries Ltd Main Business
Table 82. Teva Pharmaceutical Industries Ltd Latest Developments
Table 83. Church & Dwight Co. Inc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 85. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Church & Dwight Co. Inc Main Business
Table 87. Church & Dwight Co. Inc Latest Developments
Table 88. Reckitt Benckiser Plc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 90. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Reckitt Benckiser Plc Main Business
Table 92. Reckitt Benckiser Plc Latest Developments
Table 93. Pfizer, Inc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 95. Pfizer, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer, Inc Main Business
Table 97. Pfizer, Inc Latest Developments
Table 98. Bayer AG Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer AG Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 100. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Bayer AG Main Business
Table 102. Bayer AG Latest Developments
Table 103. Mayer Laboratories, Inc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 105. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Mayer Laboratories, Inc Main Business
Table 107. Mayer Laboratories, Inc Latest Developments
Table 108. The Female Health Company Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. The Female Health Company Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 110. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. The Female Health Company Main Business
Table 112. The Female Health Company Latest Developments
Table 113. Cooper Surgical, Inc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Cooper Surgical, Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 115. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Cooper Surgical, Inc Main Business
Table 117. Cooper Surgical, Inc Latest Developments
Table 118. Allergan plc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. Allergan plc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 120. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Allergan plc Main Business
Table 122. Allergan plc Latest Developments
Table 123. Cipla Limited Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Cipla Limited Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 125. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Cipla Limited Main Business
Table 127. Cipla Limited Latest Developments
Table 128. Merck & Co. Inc Basic Information, Contraceptives Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck & Co. Inc Contraceptives Drugs and Devices Product Portfolios and Specifications
Table 130. Merck & Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Merck & Co. Inc Main Business
Table 132. Merck & Co. Inc Latest Developments

LIST OF FIGURES

Figure 1. Picture of Contraceptives Drugs and Devices
Figure 2. Contraceptives Drugs and Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptives Drugs and Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Contraceptives Drugs and Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Contraceptives Drugs and Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Figure 10. Product Picture of Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Figure 11. Global Contraceptives Drugs and Devices Sales Market Share by Type in 2022
Figure 12. Global Contraceptives Drugs and Devices Revenue Market Share by Type (2018-2023)
Figure 13. Contraceptives Drugs and Devices Consumed in Female
Figure 14. Global Contraceptives Drugs and Devices Market: Female (2018-2023) & (K Units)
Figure 15. Contraceptives Drugs and Devices Consumed in Male
Figure 16. Global Contraceptives Drugs and Devices Market: Male (2018-2023) & (K Units)
Figure 17. Global Contraceptives Drugs and Devices Sales Market Share by Application (2022)
Figure 18. Global Contraceptives Drugs and Devices Revenue Market Share by Application in 2022
Figure 19. Contraceptives Drugs and Devices Sales Market by Company in 2022 (K Units)
Figure 20. Global Contraceptives Drugs and Devices Sales Market Share by Company in 2022
Figure 21. Contraceptives Drugs and Devices Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Contraceptives Drugs and Devices Revenue Market Share by Company in 2022
Figure 23. Global Contraceptives Drugs and Devices Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Contraceptives Drugs and Devices Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Contraceptives Drugs and Devices Sales 2018-2023 (K Units)
Figure 26. Americas Contraceptives Drugs and Devices Revenue 2018-2023 ($ Millions)
Figure 27. APAC Contraceptives Drugs and Devices Sales 2018-2023 (K Units)
Figure 28. APAC Contraceptives Drugs and Devices Revenue 2018-2023 ($ Millions)
Figure 29. Europe Contraceptives Drugs and Devices Sales 2018-2023 (K Units)
Figure 30. Europe Contraceptives Drugs and Devices Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Contraceptives Drugs and Devices Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Contraceptives Drugs and Devices Revenue 2018-2023 ($ Millions)
Figure 33. Americas Contraceptives Drugs and Devices Sales Market Share by Country in 2022
Figure 34. Americas Contraceptives Drugs and Devices Revenue Market Share by Country in 2022
Figure 35. Americas Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
Figure 36. Americas Contraceptives Drugs and Devices Sales Market Share by Application (2018-2023)
Figure 37. United States Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Contraceptives Drugs and Devices Sales Market Share by Region in 2022
Figure 42. APAC Contraceptives Drugs and Devices Revenue Market Share by Regions in 2022
Figure 43. APAC Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
Figure 44. APAC Contraceptives Drugs and Devices Sales Market Share by Application (2018-2023)
Figure 45. China Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Contraceptives Drugs and Devices Sales Market Share by Country in 2022
Figure 53. Europe Contraceptives Drugs and Devices Revenue Market Share by Country in 2022
Figure 54. Europe Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
Figure 55. Europe Contraceptives Drugs and Devices Sales Market Share by Application (2018-2023)
Figure 56. Germany Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Application (2018-2023)
Figure 65. Egypt Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Contraceptives Drugs and Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Contraceptives Drugs and Devices in 2022
Figure 71. Manufacturing Process Analysis of Contraceptives Drugs and Devices
Figure 72. Industry Chain Structure of Contraceptives Drugs and Devices
Figure 73. Channels of Distribution
Figure 74. Global Contraceptives Drugs and Devices Sales Market Forecast by Region (2024-2029)
Figure 75. Global Contraceptives Drugs and Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Contraceptives Drugs and Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Contraceptives Drugs and Devices Revenue Market Share Forecast by Application (2024-2029)


More Publications